M. Landi

2,3,7,8-Tetrachlorodibenzo-p-dioxin plasma levels in Seveso 20 years after the accident.

D. Consonni, G. Lucier, P. Brambilla, 1998, Environmental health perspectives.

Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans.

G. Clark, G. Lucier, P. Bertazzi, 1994, Pharmacogenetics.

Susceptibility markers in normal subjects: A pilot study for the investigation of 2,3,7,8-tetrachlorodibenzo-p-dioxin related diseases

G. Clark, G. Lucier, P. Bertazzi, 1993 .

Human cytochrome P4501A2.

F. Kadlubar, N. Lang, M. Landi, 1999, IARC scientific publications.

Health status and plasma dioxin levels in chloracne cases 20 years after the Seveso, Italy accident

A. Baccarelli, D. Consonni, A. Pesatori, 2005, The British journal of dermatology.

Dioxin exposure and human leukemias and lymphomas. Lessons from the Seveso accident and studies on industrial workers

D. Consonni, M. Landi, I. Bernucci, 1999, Leukemia.

Concentrations of dioxin 20 years after Seveso

G. Lucier, N. Caporaso, P. Mocarelli, 1997, The Lancet.

The debrisoquine metabolic phenotype and DNA-based assays: implications of misclassification for the association of lung cancer and the debrisoquine metabolic phenotype.

R. Hoover, C. Harris, M. Tucker, 1992, Environmental health perspectives.

A study of gender-based cytochrome P4501A2 variability: a possible mechanism for the male excess of bladder cancer.

D. Silverman, M. Tucker, G. Lambert, 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Correspondence re: letter to the editor by B. K. Tang and W. Kalow on CYP1A2 phenotyping using caffeine. Cancer Epidemiol. Biomarkers & Prev., 5: 231, 1996.

J. F. Young, N. Caporaso, F. Kadlubar, 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.